Skip to content
Review

Selected metal-organic frameworks meet biopolymers: synthesis strategies and synergistic effects for biomedical applications.

Oct 2026 · International Journal of Biological Macromolecules · pp. 155029 · 0 citations · 109 references
Medicine

Abstract

Metal-organic frameworks (MOFs) offer high surface area, tunable porosity, and modular chemistry that support biomedical applications. Pristine metal-organic frameworks face aqueous instability and safety concerns; thus, incorporation with biopolymers provides a viable strategy to enhance structural integrity. Existing literature reviews primarily focus on specific material pairings or isolated applications. To provide a systematic perspective, this review evaluates synthesis strategies and synergistic mechanisms of metal-organic framework/biopolymer composites across drug delivery, wound healing, bone tissue engineering, and cancer theranostics. Fabrication pathways encompass in-situ growth on biopolymer matrices, covalently cross-linked networks, post-synthetic coatings, and template-guided morphological engineering. Biopolymers, including chitosan, alginate, gelatin, starch, and β-cyclodextrin matrices, enhance mechanical stability and cytocompatibility. Concurrently, frameworks such as ZIF-8, MIL-53(Fe), MIL-101(Al), UiO-66, and HKUST-1 facilitate high therapeutic loading and responsive release. Biopolymer encapsulation functions as a physical diffusion barrier, mitigating initial burst release while enabling pH-responsive or redox-triggered kinetics under acidic pathological conditions. Surface functionalization preserves targeting capabilities and minimizes premature metal ion leaching. Composite dressings integrate antimicrobial activity with accelerated cellular migration for wound closure. Hydrogels and coated scaffolds promote osteogenesis and biomineralization in osteoblast cultures and rodent defect models. Furthermore, metal-organic framework/biopolymer composites enable combined chemotherapy, photothermal, or chemodynamic treatments alongside diagnostic imaging guidance. Preclinical evidence indicates that these hybrid materials address key stability limitations, offering adaptable material networks for therapeutic development.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.